OptimizeRx Corporation(OPRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

OPRX OptimizeRx Corporation

Closed 01-10 16:00:00 EST

5.36

-0.05

-0.92%

盘后5.36

+0.000.00%

16:00 EST

High5.49	Low5.08	Vol152.69K
Open5.28	D1 Closing5.41	Amplitude7.58%
Mkt Cap98.74M	Tradable Cap86.21M	Total Shares18.42M
T/O816.28K	T/O Rate0.95%	Tradable Shares16.08M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"OPRX","market":"US","secType":"STK","nameCN":"OptimizeRx Corporation","latestPrice":5.36,"timestamp":1736542800000,"preClose":5.41,"halted":0,"volume":152688,"hourTrading":{"tag":"盘后","latestPrice":5.36,"preClose":5.36,"latestTime":"16:00 EST","volume":462,"amount":2476.32,"timestamp":1736542800369},"delay":0,"floatShares":16083357,"shares":18420906,"eps":-1.343322,"marketStatus":"Closed","change":-0.05,"latestTime":"01-10 16:00:00 EST","open":5.28,"high":5.49,"low":5.08,"amount":816275.9196,"amplitude":0.075786,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.343322,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1736758800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":5.41,"postHourTrading":{"tag":"盘后","latestPrice":5.36,"preClose":5.36,"latestTime":"16:00 EST","volume":462,"amount":2476.32,"timestamp":1736542800369},"volumeRatio":0.549379,"impliedVol":0.9116,"impliedVolPercentile":0.8048},"requestUrl":"/m/hq/s/OPRX/wiki","defaultTab":"wiki","newsList":[{"id":"2501472022","title":"OptimizeRx downgraded to \"sector perform\" by RBC amid slower growth outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2501472022","media":"Investing.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501472022?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:37","pubTimestamp":1736343454,"startTime":"0","endTime":"0","summary":"Investing.com -- RBC Capital Markets has downgraded OptimizeRx Corp  to \"sector perform,\" reflecting a tempered outlook on the company's growth prospects.RBC analysts cited challenges in the company's direct-to-consumer segment, particularly as clients transition to a self-service model that generates lower revenue but offers higher margins.This shift, coupled with weaker bookings attributed to the timing of the Medicx acquisition in late 2023, is expected to dampen revenue growth through the first half of 2025.OptimizeRx's updated revenue projections for 2025 have been revised downward to $94 million, reflecting a modest 2.7% growth compared to an earlier forecast of 11%.This adjustment aligns with RBC's recalibrated EBITDA estimate, now at $10.4 million for 2025, reflecting subdued growth expectations. Consequently, RBC has also lowered its price target for the stock to $6 from $7.The company's challenges in the DTC business are partly offset by growth in its healthcare provider-focu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/optimizerx-downgraded-sector-perform-rbc-133734680.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OPRX"],"gpt_icon":0},{"id":"2501729112","title":"OptimizeRx Cut to Sector Perform From Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2501729112","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501729112?lang=en_us&edition=fundamental","pubTime":"2025-01-08 20:46","pubTimestamp":1736340360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OPRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 08, 2025 07:46 ET (12:46 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPRX"],"gpt_icon":0},{"id":"2501403817","title":"RBC Downgrades OptimizeRx to Sector Perform From Outperform, Cuts Price Target to $6 From $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2501403817","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501403817?lang=en_us&edition=fundamental","pubTime":"2025-01-08 19:25","pubTimestamp":1736335539,"startTime":"0","endTime":"0","summary":"OptimizeRx (OPRX) has an average rating of overweight and mean price target of $9.64, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPRX"],"gpt_icon":0},{"id":"2501231749","title":"OptimizeRx (OPRX) was downgraded to a Hold Rating at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2501231749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501231749?lang=en_us&edition=fundamental","pubTime":"2025-01-08 18:17","pubTimestamp":1736331452,"startTime":"0","endTime":"0","summary":"In a report released today, Sean Dodge from RBC Capital downgraded OptimizeRx (OPRX – Research Report) to a Hold, with a price target of $6.00. The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/optimizerx-oprx-was-downgraded-to-a-hold-rating-at-rbc-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/optimizerx-oprx-was-downgraded-to-a-hold-rating-at-rbc-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPRX"],"gpt_icon":0},{"id":"2494037555","title":"OptimizeRx Price Target Maintained With a $11.00/Share by Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2494037555","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494037555?lang=en_us&edition=fundamental","pubTime":"2024-12-25 02:06","pubTimestamp":1735063560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OPRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 24, 2024 13:06 ET (18:06 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPRX"],"gpt_icon":0},{"id":"2493271087","title":"OptimizeRx Is Maintained at Buy by B. Riley Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2493271087","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493271087?lang=en_us&edition=fundamental","pubTime":"2024-12-24 22:53","pubTimestamp":1735051980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OPRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 24, 2024 09:53 ET (14:53 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPRX","RILY"],"gpt_icon":0},{"id":"2493089085","title":"Lake Street reiterates Buy on OptimizeRx after ‘surprising’ CEO departure","url":"https://stock-news.laohu8.com/highlight/detail?id=2493089085","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493089085?lang=en_us&edition=fundamental","pubTime":"2024-12-24 21:40","pubTimestamp":1735047610,"startTime":"0","endTime":"0","summary":"Lake Street was surprised at the news OptimizeRx’s (OPRX) CEO Will Febbo will be resigning December 31st. While the firm believes President Steve S...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lake-street-reiterates-buy-on-optimizerx-after-surprising-ceo-departure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lake-street-reiterates-buy-on-optimizerx-after-surprising-ceo-departure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPRX","BK4167"],"gpt_icon":0},{"id":"2493083924","title":"B. Riley Cuts Price Target on OptimizeRx to $13 From $17, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2493083924","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493083924?lang=en_us&edition=fundamental","pubTime":"2024-12-24 20:34","pubTimestamp":1735043699,"startTime":"0","endTime":"0","summary":"OptimizeRx (OPRX) has an average rating of buy and mean price target of $9.79, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RILY","OPRX"],"gpt_icon":0},{"id":"2493780700","title":"Stifel Nicolaus Keeps Their Buy Rating on OptimizeRx (OPRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2493780700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493780700?lang=en_us&edition=fundamental","pubTime":"2024-12-24 19:55","pubTimestamp":1735041306,"startTime":"0","endTime":"0","summary":"In a report released yesterday, David Grossman from Stifel Nicolaus maintained a Buy rating on OptimizeRx (OPRX – Research Report), with a price ta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-keeps-their-buy-rating-on-optimizerx-oprx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-keeps-their-buy-rating-on-optimizerx-oprx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPRX","SF"],"gpt_icon":0},{"id":"2493765571","title":"OptimizeRx Names Stephen Silverstro as Interim CEO, Sees FY24 Revenue At High End of Guidance Range","url":"https://stock-news.laohu8.com/highlight/detail?id=2493765571","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493765571?lang=en_us&edition=fundamental","pubTime":"2024-12-23 22:31","pubTimestamp":1734964314,"startTime":"0","endTime":"0","summary":"OptimizeRx  said Monday that Chief Executive William J. Febbo will leave the company, effective Dec. 31 and that it appointed Stephen Silvestro as interim CEO.The digital health technology company said its board hired a search firm to assist in the transition and to help look for a successor. Silvestro was the company's chief commercial officer before becoming president last year, OptimizeRx said.OptimizeRx said it expects full-year 2024 revenue to come in at the higher end of the $88 million to $92 million guidance range.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPRX"],"gpt_icon":0},{"id":"2493768230","title":"OptimizeRx announces departure of CEO Febbo, appoint Silvestro as interim CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2493768230","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493768230?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:50","pubTimestamp":1734961813,"startTime":"0","endTime":"0","summary":"OptimizeRx (OPRX) announced that William Febbo, Chief Executive Officer, CEO, and Board Member, will be departing the Company, effective as of Dece...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimizerx-announces-departure-of-ceo-febbo-appoint-silvestro-as-interim-ceo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimizerx-announces-departure-of-ceo-febbo-appoint-silvestro-as-interim-ceo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","OPRX"],"gpt_icon":0},{"id":"2493750277","title":"OptimizeRx Corp: Reaffirms Its Financial Guidance for Full Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2493750277","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493750277?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:45","pubTimestamp":1734961500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nTUA9HCN9P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","OPRX"],"gpt_icon":0},{"id":"2493750274","title":"OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2493750274","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493750274?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:45","pubTimestamp":1734961500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nTUA9HCN9P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OPRX","BK4167"],"gpt_icon":0},{"id":"2493502727","title":"OptimizeRx: Expects FY Results Will Come in at Higher End of Its Guidance Range for Revenue & Adjusted Ebitda","url":"https://stock-news.laohu8.com/highlight/detail?id=2493502727","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493502727?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:45","pubTimestamp":1734961500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nTUA9HCN9P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","OPRX"],"gpt_icon":0},{"id":"2493750203","title":"Press Release: OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2493750203","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493750203?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:45","pubTimestamp":1734961500,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., Dec. 23, 2024  -- OptimizeRx Corp.  , a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals  and patients, today announced that William J. Febbo, Chief Executive Officer  and Board Member, will be departing the Company, effective as of December 31, 2024, to pursue other opportunities. Mr. Febbo will provide the Company with advisory services through March 31, 2025. The Company's Board of Directors has retained a search firm to assist in this transition.\"The time is right to pass the reins on to an incredible team, ready to carry the legacy forward with strength and purpose,\" underscored Mr. Febbo. \"With a clear market opportunity and the ability to deliver, they have my ongoing and unwavering support.\". OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPRX","BK4167","CEO"],"gpt_icon":0},{"id":"2492444847","title":"Stephens Initiates Coverage on OptimizeRx With Equal Weight Rating, $5.50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2492444847","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492444847?lang=en_us&edition=fundamental","pubTime":"2024-12-20 21:07","pubTimestamp":1734700072,"startTime":"0","endTime":"0","summary":"OptimizeRx (OPRX) has an average rating of Buy and mean price target of $10.36, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks an","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPRX"],"gpt_icon":0},{"id":"2492484258","title":"OptimizeRx initiated with an Equal Weight at Stephens","url":"https://stock-news.laohu8.com/highlight/detail?id=2492484258","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492484258?lang=en_us&edition=fundamental","pubTime":"2024-12-20 05:30","pubTimestamp":1734643850,"startTime":"0","endTime":"0","summary":"Stephens initiated coverage of OptimizeRx (OPRX) with an Equal Weight rating and $5.50 price target The firm says the company’s “evolving” direct-t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimizerx-initiated-with-an-equal-weight-at-stephens?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimizerx-initiated-with-an-equal-weight-at-stephens?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPRX","BK4167"],"gpt_icon":0},{"id":"2492968571","title":"Analysts Conflicted on These Healthcare Names: OptimizeRx (OPRX) and Universal Health (UHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2492968571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492968571?lang=en_us&edition=fundamental","pubTime":"2024-12-17 22:10","pubTimestamp":1734444614,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on OptimizeRx (OPRX – Research Report) and Universal Health (UHS – R...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-optimizerx-oprx-and-universal-health-uhs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-optimizerx-oprx-and-universal-health-uhs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","HCSG","BK4185","BK4588","BK4137","UHS","BK4585","OPRX"],"gpt_icon":0},{"id":"2484062741","title":"OptimizeRx to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2484062741","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484062741?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:30","pubTimestamp":1731933000,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., Nov. 18, 2024  -- OptimizeRx Corp. ,a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional  and patients, today announced that management will participate in the following upcoming investor conferences:. 13th Annual ROTH Technology Conference, New York City, November 19th – 20th, 2024. Canaccord Genuity’s 2024 CG MedTech, Diagnostics and Digital Health & Services Forum, New York City, November 21st, 2024. To request a meeting or for more details about the conferences please reach out to your institutional contact or email.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/AMImFdBNZ.vouVAh4J9vIQ--~B/aD0zMDA7dz0xMjc1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/213f5d3738e6580d338354a848b3f901","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/AMImFdBNZ.vouVAh4J9vIQ--~B/aD0zMDA7dz0xMjc1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/213f5d3738e6580d338354a848b3f901"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/optimizerx-participate-upcoming-investor-conferences-123000174.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OPRX","BK4167"],"gpt_icon":0},{"id":"2483383174","title":"OptimizeRx Price Target Cut to $16.00/Share From $20.00 by Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2483383174","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483383174?lang=en_us&edition=fundamental","pubTime":"2024-11-15 00:00","pubTimestamp":1731600000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OPRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2024 11:00 ET (16:00 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.optimizerx.com","stockEarnings":[{"period":"1week","weight":0.1132},{"period":"1month","weight":0.0344},{"period":"3month","weight":-0.1766},{"period":"6month","weight":-0.4691},{"period":"1year","weight":-0.6443},{"period":"ytd","weight":0.1132}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0251},{"period":"3month","weight":0.0232},{"period":"6month","weight":0.0527},{"period":"1year","weight":0.244},{"period":"ytd","weight":0.0058}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.062993},{"month":2,"riseRate":0.666667,"avgChangeRate":0.055816},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.115451},{"month":4,"riseRate":0.5,"avgChangeRate":-0.074092},{"month":5,"riseRate":0.5,"avgChangeRate":0.099038},{"month":6,"riseRate":0.833333,"avgChangeRate":0.062928},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.02887},{"month":8,"riseRate":0.571429,"avgChangeRate":0.002178},{"month":9,"riseRate":0.428571,"avgChangeRate":0.056563},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.051657},{"month":11,"riseRate":0.571429,"avgChangeRate":0.059021},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.005062}],"exchange":"NASDAQ","name":"OptimizeRx Corporation","nameEN":"OptimizeRx Corporation"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"OptimizeRx Corporation(OPRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest OptimizeRx Corporation(OPRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"OptimizeRx Corporation,OPRX,OptimizeRx Corporation股票,OptimizeRx Corporation股票老虎,OptimizeRx Corporation股票老虎国际,OptimizeRx Corporation行情,OptimizeRx Corporation股票行情,OptimizeRx Corporation股价,OptimizeRx Corporation股市,OptimizeRx Corporation股票价格,OptimizeRx Corporation股票交易,OptimizeRx Corporation股票购买,OptimizeRx Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"OptimizeRx Corporation(OPRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest OptimizeRx Corporation(OPRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction